Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parabel is a biotechnology company focused on the sustainable production of plant-based proteins and ingredients derived from water lentils (Lemnaceae). The company utilizes a proprietary hydroponic growth system to cultivate these plants, which are then processed into high-quality nutritional products such as LENTEIN protein. Their offerings are marketed as nutrient-dense, allergen-free alternatives to traditional plant proteins like soy and pea. Parabel's technology emphasizes environmental sustainability, featuring a water-recycling system and a minimal carbon footprint. The company serves the global food, beverage, and nutraceutical industries with products designed to address nutritional deficiencies and support muscle health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parabel.